Oarsman Capital, Inc. Abbott Laboratories Transaction History
Oarsman Capital, Inc.
- $562 Million
- Q4 2024
A detailed history of Oarsman Capital, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Oarsman Capital, Inc. holds 5,505 shares of ABT stock, worth $729,963. This represents 0.11% of its overall portfolio holdings.
Number of Shares
5,505
Previous 5,475
0.55%
Holding current value
$729,963
Previous $624,000
0.32%
% of portfolio
0.11%
Previous 0.12%
Shares
27 transactions
Others Institutions Holding ABT
# of Institutions
3,503Shares Held
1.35BCall Options Held
10.5MPut Options Held
8.77M-
Vanguard Group Inc Valley Forge, PA170MShares$22.5 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.2 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$9.01 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.17 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $232B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...